Pfizer’s Bourla Defends Strategy In The Wake Of Starboard’s Activist Investment

CEO Albert Bourla said Starboard Value’s push for change at Pfizer is coming 15 months late as the company is already executing a five-point plan to cut costs and pivot on strategy.